| 2026-04-13 | 2025 | Jack Yongfeng Zhang | Chief Chief Executive Officer, President President, Chief Chief Scientific Officer | Founder / CEO | $950.91K | $329.75K | $3.30M | $3.30M | $361.00K | $63.69K | $8.31M |
| 2026-04-13 | 2025 | Mary Ziping Luo | Chief Chief Operating Officer, Chief Chief Scientist and Chairman | C-Level | $775.12K | $288.92K | $1.39M | $1.39M | $128.00K | $55.03K | $4.03M |
| 2026-04-13 | 2025 | William J. Peters | Chief Chief Financial Officer, Executive Vice Vice President President of Finance, Treasurer, President President of International Medication Systems, Limited, and Director Director | C-Level | $649.85K | $370.31K | $1.04M | $1.04M | $73.00K | $57.52K | $3.24M |
| 2026-04-13 | 2025 | Rong Zhou | Senior Senior Executive Vice Vice President President of Production and President President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | C-Level | $717.59K | $280.48K | $701.50K | $701.51K | $98.00K | $43.56K | $2.54M |
| 2026-04-13 | 2025 | Jacob Liawatidewi Executive | Vice Vice President President of Sales and Marketing, Executive Vice Vice President President of Corporate Administration Center and President President of Amphastar France Pharmaceuticals, S.A.S. | C-Level | $499.91K | $265.20K | $591.98K | $592.03K | $47.00K | $41.74K | $2.04M |
| 2026-04-13 | 2024 | Jack Yongfeng Zhang | Chief Chief Executive Officer, President President, Chief Chief Scientific Officer | Founder / CEO | $915.31K | $317.08K | $3.00M | $3.00M | $444.00K | $54.36K | $7.73M |
| 2026-04-13 | 2024 | Mary Ziping Luo | Chief Chief Operating Officer, Chief Chief Scientist and Chairman | C-Level | $746.04K | $314.72K | $1.27M | $1.27M | $163.00K | $43.93K | $3.80M |
| 2026-04-13 | 2024 | William J. Peters | Chief Chief Financial Officer, Executive Vice Vice President President of Finance, Treasurer, President President of International Medication Systems, Limited, and Director Director | C-Level | $625.53K | $292.62K | $907.46K | $907.55K | $121.00K | $56.71K | $2.91M |
| 2026-04-13 | 2024 | Rong Zhou | Senior Senior Executive Vice Vice President President of Production and President President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | C-Level | $564.48K | $235.08K | $584.48K | $584.52K | $116.00K | $43.36K | $2.13M |
| 2026-04-13 | 2024 | Jacob Liawatidewi Executive | Vice Vice President President of Sales and Marketing, Executive Vice Vice President President of Corporate Administration Center and President President of Amphastar France Pharmaceuticals, S.A.S. | C-Level | $480.79K | $220.38K | $502.00K | $502.02K | $75.00K | $41.58K | $1.82M |
| 2026-04-13 | 2023 | Jack Yongfeng Zhang | Chief Chief Executive Officer, President President, Chief Chief Scientific Officer | Founder / CEO | $898.00K | $310.85K | $2.86M | $2.86M | $736.00K | $59.91K | $7.72M |
| 2026-04-13 | 2023 | Mary Ziping Luo | Chief Chief Operating Officer, Chief Chief Scientist and Chairman | C-Level | $732.00K | $309.63K | $1.20M | $1.21M | $280.00K | $43.01K | $3.77M |
| 2026-04-13 | 2023 | William J. Peters | Chief Chief Financial Officer, Executive Vice Vice President President of Finance, Treasurer, President President of International Medication Systems, Limited, and Director Director | C-Level | $612.58K | $283.23K | $840.49K | $840.53K | $261.00K | $55.48K | $2.89M |
| 2026-04-13 | 2023 | Rong Zhou | Senior Senior Executive Vice Vice President President of Production and President President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | C-Level | $542.33K | $209.88K | $531.48K | $531.53K | $167.00K | $43.09K | $2.03M |
| 2026-04-13 | 2023 | Jacob Liawatidewi Executive | Vice Vice President President of Sales and Marketing, Executive Vice Vice President President of Corporate Administration Center and President President of Amphastar France Pharmaceuticals, S.A.S. | C-Level | $495.55K | $195.85K | $447.98K | $448.02K | $148.00K | $40.70K | $1.78M |